BCG + Mitomycin trial for high-risk non-muscle-invasive bladder cancer: progress report and lessons learned

Dickon Hayne; Martin R Stockler; Steve P McCombie; Nicola Lawrence; Andrew Martin; Shomik Sengupta; Ian D. Davis

doi:10.1111/bju.13873

BCG + Mitomycin trial for high-risk non-muscle-invasive bladder cancer: progress report and lessons learned

Dickon Hayne, Martin R Stockler, Steve P McCombie, Nicola Lawrence, Andrew Martin, Shomik Sengupta, Ian D. Davis

Eastern Health Clinical School Research

Research output: Contribution to journal › Comment / Debate › Other › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	55-57
Number of pages	3
Journal	BJU International
Volume	119
DOIs	https://doi.org/10.1111/bju.13873
Publication status	Published - 1 May 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/bju.13873

Cite this

@article{25123a972f3e43f583519dc6e178ee1f,

title = "BCG + Mitomycin trial for high-risk non-muscle-invasive bladder cancer: progress report and lessons learned",

author = "Dickon Hayne and Stockler, {Martin R} and McCombie, {Steve P} and Nicola Lawrence and Andrew Martin and Shomik Sengupta and Davis, {Ian D.}",

year = "2017",

month = may,

day = "1",

doi = "10.1111/bju.13873",

language = "English",

volume = "119",

pages = "55--57",

journal = "BJU International",

issn = "1464-4096",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - BCG + Mitomycin trial for high-risk non-muscle-invasive bladder cancer

T2 - progress report and lessons learned

AU - Hayne, Dickon

AU - Stockler, Martin R

AU - McCombie, Steve P

AU - Lawrence, Nicola

AU - Martin, Andrew

AU - Sengupta, Shomik

AU - Davis, Ian D.

PY - 2017/5/1

Y1 - 2017/5/1

UR - http://www.scopus.com/inward/record.url?scp=85019893512&partnerID=8YFLogxK

U2 - 10.1111/bju.13873

DO - 10.1111/bju.13873

M3 - Comment / Debate

AN - SCOPUS:85019893512

SN - 1464-4096

VL - 119

SP - 55

EP - 57

JO - BJU International

JF - BJU International

ER -

BCG + Mitomycin trial for high-risk non-muscle-invasive bladder cancer: progress report and lessons learned

UN SDGs

Access to Document

Other files and links

Cite this